Introduction
for assessment of progression rate of chronic renal failure. The time period during which creatinine serum concentration doubles is used as a parameter for assessing progression of chronic renal failure and efficacy of applied therapy (2) . In hypertensive patients or those with family history of renal diseases and pathological findings in urine, or with serum creatinine concentration above normal values, GFR should be determined. Endogenous creatinine clearance and clearance of radionuclide isotopes are used for the assessment of GFR. The golden standard for determining GFR is clearance of inulin and other markers, such as 125 I -iothalamate (4 -6).
Cystatin C serum concentration can also be used for the assessment of GFR. Cystatin C is a plasma protein with molecular weight of 13 kD. Due to its low molecular weight, it is easily filtered through glomerular basement membrane, and more than 99% is reabsorbed in epithelial cells of proximal tubules. Therefore, because of its constant rate of production by nucleated cells, its serum concentration is determined by glomerular filtration, which makes it a good marker of GFR (7) (8) (9) (10) (11) (12) (13) (14) (15) . There is no statistically significant difference between serum cystatin C concentration in men and women. Normal cystatin C values, as suggested by NCCLS (National Committee for Clinical Laboratory Standards) range from 0.54 to 1.21 mg/L (3). It is determined by immunonephelometric method. Combined measurement of cystatin C serum concentration and its urine excretion is useful in the assessment of early decrease of GFR and proximal tubules damage (17, 18) . Daily urine excretion of cystatin C is 0.0074 ± 0.0034 mg. Very low cystatin C concentration in urine (< 0.3 mg/L) limits its routine use in assessment of tubulointerstitial damage.
The aim of this study was to determine the influence of various proteinuria levels on cystatin C serum concentration.
Patients and Methods
The study included 45 patients treated at the Institute of Urology and Nephrology, Clinical Center of Serbia in Belgrade, over a period of one year. All subjects gave informed consent to participate in the study, according to Helsinki Declaration on Medical Research.
Patients included in the study had primary glomerular diseases, endogenous creatinine clearance > 80 mL/min and various levels of glomerular proteinuria. Urinary infection was excluded by microscopic and microbiologic examination of each urine sample.
Patients were divided into three groups based on proteinuria levels: group I (control) with proteinuria < 0.25 g/24h, group II (nonnephrotic proteinuria) with proteinuria 0.25-3.5 g/24h and group III (nephrotic proteinuria) with proteinuria > 3.5 g/24h ( Table I ).
Blood and urine samples were taken in the morning. Twenty-four hour urine was collected from 6 A.M. one day to 6 A.M. the next day. Creatinine concentration in serum was determined by colorimetric test, on Monarch plus IL, Milan, Italy, apparatus. Creatinine concentration in 24h urine was determined in the same way with ten times higher dilution. Urea serum concentration was determined by enzyme method (urease-glutamat dehydrogenase) on the same apparatus.
Proteinuria in samples of 24h urine was determined by colorimetric test with CBB. Cystatin C serum concentration was determined by PENIA method (Particle-Enhanced Nephelometric Immuno-Assay) from Dade-Behring Co. The reference range for cystatin C serum concentration is 0.54 -1.21 mg/L. Coloid-osmotic pressure (COP) was calculated from the equation (19):
proteinuria ³ 3.5 g/24h a = 0.13 i b = 2.07 proteinuria < 3.5 g/24h a = -1.15 i b = 3.03, where P stands for plasma total protein concentration (g/L) and Alb represents plasma albumin concentration (g/L). Normal COP ranges from 24 to 26 mmHg.
Group differences were tested by the Student ttest and Mann-Whitney U test.
Results
In order to assess renal function, we determined urea, creatinine and cystatin C serum concentrations, proteinuria and endogenous creatinine clearance in patients with primary glomerular diseases. Results are shown in Table II .
No statistically significant differences were found between groups concerning serum urea and creatinine, and endogenous creatinine clearance values.
Patients with proteinuria >3.5 g/24h had significantly lower total proteins and albumin serum concentrations (p<0.01) than patients with proteinuria range 0.25 '3.5 g/24h (Table II) . Between other patients' groups, no statistically significant differences were found concerning serum albumin and total proteins concentration (p>0.05).
Patients with proteinuria > 3.5 g/24h had significantly lower COP (p<0.01) than control subjects and patients with nonnephrotic proteinuria. No statistically significant difference in COP was found between other groups (p>0.05).
The mean values of cystatin C in examined groups were normal, but higher in patients with proteinuria. All parameters are presented in Tables I and II. No statistically significant difference in cystatin C serum values (p>0.05) was found between groups.
Discussion
Serum cystatin C concentration was used to estimate renal function, as it is a better marker of GFR decrease than serum creatinine and clearance of endogenous creatinine.
By investigating the correlation between GFR (determined by clearance of 51 Cr-EDTA), serum cystatin C and serum creatinine, it was found that cystatin C is a better marker for GFR than serum creatinine concentration (20) . By investigating correlations between 99m Tc-DTPA clearance and 1/cys C, 1/creatinine and endogenous creatinine clearance (CCr), it was found that correlation between 99m Tc-DTPA clearance and 1/cys C was the best (17, 18) . In patients with normal and mild renal insufficiency ( 99m Tc- N -number of subjects, SD -standard deviation, COP -plasma colloid-osmotic pressure DTPA clearance 50 ' 80 mL/min) cystatin C is a liable marker of GFR (17, 18, 20) . Assessment of GFR by radionuclid clearance is not safe to perform in patients with progressive renal diseases and GFR values lower than 20'30 mL/min (10).
Combined measurement of cystatin C concentration in serum and in urine is valuable for assessing early decrease of GFR and damage of proximal tubules (21) . Proteinuria has no statistically significant influence on cystatin C serum concentration in patients with endogenous creatinine clearance > 80 mL/min. Patients with endogenous creatinine clearance < 30 mL/min excrete significantly higher amounts of cystatin C in urine than subjects with normal endogenous creatinine clearance values. Increase of fraction cystatin C clearance represents deterioration of proximal tubule epithelial cells function (7) .
Renal function gradualy decreases in patients with chronic renal diseases. Measuring creatinine serum concentration as the marker for GFR should be performed at least once a year in patients with chronic renal diseases, and even more often in patients with GFR < 60 mL/min/1.73 m 2 , rapid decrease of GFR (≥ 4 mL/min/1.73 m 2 /year), risk factors that contribute to rapid decrease of renal function, during treatment for slowing down the progression of renal disease, and during exposure to risk factors for acute decrease of GFR (4, 5) . In patients with chronic kidney diseases, renal function decreases progressively, irrespective of cessation of primary event that caused the disease. In patients with GFR < 60 mL/min/1.73 m 2 end-stage renal failure (GFR < 15 mL/min/1.73 m 2 ) develops in 10 years. Decrease rate of renal function is ≥ 4 mL/min/1.73 m 2 /year (4, 5).
Proteinuria has no statistically significant influence on cystatin C serum concentration in patients with primary glomerulonephritis and endogenous creatinine clearance over 80 mL/min. Kratak sadr`aj: Cistatin C je protein male molekulske mase koji mo`e da se koristi za procenu ja~ine glomerulske filtracije. Ispitivanjem stepena povezanosti izme|u JGF (odre|ene pomo}u 51 Cr-EDTA klirensa), cistatina C i kreatinina u serumu, utvr|eno je da je cistatin C bolji pokazatelj JGF u odnosu na koncentraciju kreatinina u serumu jer je poznato da se 50% JGF izgubi pre nego {to do|e do zna~ajnije promene u koncentraciji serumskog kreatinina. Koncentracija cistatina C u serumu uglavnom zavisi od ja~ine glomerulske filtracije. Kombinovano merenje koncentracije cistatina C u serumu i koli~ine izlu~ivanja cistatina C mokra}om, korisno je za procenu po~etnog smanjenja ja~ine glomerulske filtracije i o{te}enja proksimalnih tubula bubrega. Zbog toga je cilj ovog rada bio da se ispita uticaj proteinurije na koncentraciju cistatina C u serumu. Pored odre|ivanja koncentracija cistatina C u serumu i proteina u 24h urinu, odre|ene su i koncentracija uree, kreatinina, ukupnih proteina i albumina u serumu, koloidno-osmotski pritisak plazme (COP) i klirens endogenog kreatinina. Ispitano je 45 bolesnika (28 mu{karaca i 17 `ena), prose~ne starosti 39,51 ± 7,60 godina, sa prose~nim klirensom endogenog kreatinina 97,70 ± 12,08 mL/min. Zavisno od stepena glomerulske preteinurije ispitanici su podeljeni u tri grupe. U prvoj grupi sa proteinurijom < 0,25 g/24h (kontrolna grupa) bilo je 15 osoba (6 mu{karaca i 9 `ena), prose~ne starosti 37,27 ± 5,48 godina, s prose~nim klirensom endogenog kreatinina 99,70 ± 12,94 mL/min. Druga grupa sa proteinurijom nenefrotskog ranga od 0,25 do 3,5 g/24h imala je 15 bolesnika (11 mu{karaca i 4 `ene) sa PGN, prose~me starosti 38,93 ± 8,32 godina, s prose~nim klirensom endogenog kreatinina 94,00 ± 11,10 mL/min. Tre}u grupu sa proteinurijom nefrotskog ranga >3,5 g/24h ~inilo je 15 bolesnika (11 mu{karaca i 4 `ene) koji boluju od PGN, prose~ne starosti 42,33 ± 8,23 godina, s prose~nim klirensom endogenog kreatinina 99,40 ± 12,07 mL/min. Za statisti~ku analizu dobijenih podataka kori{}eni su Student-ov T-test i Mann Whitney-ev U-test. Prag zna~ajnosti bila je verovatno}a od 0,05 i 0,01. Utvr|eno je da proteinurija nema statisti~ki zna~ajnog uticaja na koncentraciju cistatina C u serumu kod bolesnika sa primarnim glomerulonefritisom i klirensom endogenog kreatinina > 80 mL/min tako da je cistatin C stabilan parametar za procenu JGF i u stanjima proteinurija.
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